Target Therapies Resistance Molecular Profiling in Patients With Neoplastic Disease

NCT03347318 · clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
2500
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Fondazione del Piemonte per l'Oncologia